首页 | 本学科首页   官方微博 | 高级检索  
检索        

冠心病患者介入治疗后血CRP、MMP-9水平与预后的关系
引用本文:赵亮,谢伟,刘俊明,黄文军.冠心病患者介入治疗后血CRP、MMP-9水平与预后的关系[J].心血管康复医学杂志,2014(4):432-435.
作者姓名:赵亮  谢伟  刘俊明  黄文军
作者单位:新疆生产建设兵团医院心内科,新疆乌鲁木齐830002
摘    要:目的:探讨冠心病(CHD)患者介入治疗前后外周血 C 反应蛋白(CRP)、基质金属蛋白酶-9(MMP-9s)水平变化,并分析其与患者预后之间的关系。方法:入选2009年7月~2011年4月在我院行冠脉支架植入术的CHD 患者278例为介入组,未行支架植入的 CHD 患者234例为 CHD 对照组。根据冠脉造影结果,介入组进一步分为单支(143例)、双支(92例)和三支病变组(43例)。比较两组患者不同时间 CRP、MMP-9水平变化,并分析其与冠脉病变及患者预后之间的关系。结果:与入院时比较,支架植入术后24h,48h,介入组患者 CRP (2.43±0.62)mg/L 比(2.87±0.73)mg/L,(2.98±0.87)mg/L]、MMP-9水平(12.63±2.68)ng/ml 比(14.62±3.49)ng/ml,(19.62±4.63)ng/ml]显著上升(P <0.05~<0.01);而术后第14d 与患者入院时差异无统计学意义,P >0.05;CHD 对照组患者在治疗过程中 CRP 和 MMP-9水平差异均无统计学意义,P >0.05;冠脉病变越严重,CRP、MMP-9水平越高,三支病变组的 CRP、MMP-9水平(2.51±0.64)mg/L,(14.67±2.97)ng/ml]显著高于单支病变(1.83±0.51)mg/L,(9.68±1.42)ng/ml]、双支病变组(2.17±0.59)mg/L,(11.62±2.19) ng/ml],P <0.05~<0.01;CRP≥3 mg/L、MMP-9≥15 ng/ml 者心血管事件发生率(33.3%、29.1%)分别显著高于 CRP <3 mg/L、MMP-9<15 ng/ml 者(16.1%、18.2%),差异均有统计学意义,P 均<0.05。结论:冠心病患者行支架植入术后48h 内其血清 C 反应蛋白、基质金属蛋白酶-9水平显著升高,并且升高水平与冠脉病变程度及预后有关。

关 键 词:冠状动脉疾病  血管成形术  经腔  经皮冠状动脉  C反应蛋白质  明胶酶B

Relationship among blood levels of CRP and MMP-9 and prognosis in patients with coronary heart dis-ease and PCI
ZHAO Liang,XIE Wei,LIU Jun-ming,HUANG Wen-jun.Relationship among blood levels of CRP and MMP-9 and prognosis in patients with coronary heart dis-ease and PCI[J].Chinese Journal of Cardiovascular Rehabilitation Medicine,2014(4):432-435.
Authors:ZHAO Liang  XIE Wei  LIU Jun-ming  HUANG Wen-jun
Institution:(Department of Cardiology, Hospital of Xinjiang Production & Construction Corps, Urumqi, Xinjiang, 830002, China)
Abstract:Objective:To explore changes of peripheral blood levels of C reactive protein (CRP)and matrix metallo-proteinase-9 (MMP-9)in patients with coronary heart diseases (CHD)and percutaneous coronary intervention (PCI),and analyze their relationship with patients'prognosis.Methods:A total of 278 CHD patients undergoing PCI in our hospital from Jul 2009 to Apr 2011 were regarded as PCI group;another 234 CHD patients not receiving PCI were enrolled as CHD control group.According to results of coronary angiography,PCI group was further di-vided into single-vessel (n=143),double-vessel (n=92)and triple-vessel disease group (n=43).Changes of CRP and MMP-9 levels were compared between two groups in different time,and the relationship among these two in-flammatory factors and coronary disease,its prognosis was analyzed.Results:Compared with on admission,there were significant rise in levels of CRP (2.43±0.62)mg/L vs.(2.87±0.73)mg/L,(2.98±0.87)mg/L]and MMP-9 (12.63±2.68)ng/ml vs.(14.62±3.49)ng/ml,(19.62±4.63)ng/ml]in PCI group on 24h and 48h after PCI,P 〈0.05~〈0.01;there were no significant difference in CRP and MMP-9 levels between on admission and 14d after PCI,P 〉0.05;The more severe coronary lesion was,the higher CRP and MMP-9 levels were,CRP and MMP-9 levels of triple-vessel group (2.51 ±0.64)mg/L,(14.67±2.97)ng/ml]were significantly higher than those of single-vessel group (1.83±0.51)mg/L,(9.68±1.42)ng/ml]and double-vessel group (2.17±0.59) mg/L,(11.62±2.19)ng/ml],P 〈0.05~〈0.01;incidence rates of cardiovascular events in patients with CRP≥3 mg/L and MMP-9≥15 ng/ml (33.3%,29.1%)were significantly higher than those of patients with CRP 〈3 mg/L and MMP-9〈15 ng/ml (16.1%,18.2%)respectively,P 〈0.05 both.Conclusion:Serum levels of CRP and MMP-9 significantly rise in CHD patients on 48h after PCI,and their increasing level is related with extent of coronary ar-tery lesion and prognosis.
Keywords:Coronary disease  Angioplasty  transluminal  percutaneous coronary  C-reactive protein  Gelatinase B
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号